Skinny Shot Max is a gastric inhibitory polypeptide (GIP) and glucagon receptor agonist that also targets the appetite hormone, glucagon-like peptide-1 (GLP-1)
the viscosity is preferably lower than 500 cP, more preferably lower than 400 cP
Applicable Procedure Code: 19318
Ongoing laboratory research continues to expand the understanding of its biochemical activity and role in cellular metabolic processes within controlled experimental models
Serious side effects are possible, including liver injury, increased risk for opioid withdrawal, and life threatening opioid intoxication
The UK medicines regulator, the MHRA, has updated the product information for healthcare professionals and patients regarding the "small risk of severe acute pancreatitis in patients taking GLP-1s." While rare, the sheer scale of GLP-1 use in the UK with one recent study suggesting 1.6 million adults had used them in the last 12 months, and 3.3 million were interested in trying them in the following year makes it important for clinicians and patients to be aware of the warning signs of pancreatitis, said the regulator